Junctin Activators
Junctin is a specialized protein found primarily within muscle cells, where it plays a pivotal role in the intricate ballet of calcium signaling. This protein is chiefly localized to the junctional face membrane of the sarcoplasmic reticulum, a critical structure in muscle cells responsible for the storage and release of calcium ions that directly trigger muscle contraction. Junctin, in concert with other proteins such as calsequestrin and the ryanodine receptor, forms a complex that ensures the precise release of calcium. The significance of junctin extends beyond its role in muscle contraction; it is integral to maintaining the delicate balance of calcium ions within muscle cells, which is vital for both the health and the proper functioning of these cells. The expression of junctin is a tightly regulated process, as its levels within the cell can influence the efficiency and regulation of calcium signaling.
In the cellular environment, the expression of junctin is subject to modulation by a variety of chemical compounds that interact with different cellular pathways. For instance, compounds such as isoproterenol and phenylephrine can upregulate junctin expression through their action on adrenergic receptors, which play a role in the sympathetic nervous system's regulation of heart rate and muscle contraction. This can lead to an increase in intracellular calcium levels, necessitating an increased production of junctin to manage this surge. Other compounds, such as digoxin, exert their influence by inhibiting specific ion pumps, resulting in elevated cytosolic calcium levels, which can also signal the need for more junctin. Additionally, chemicals like forskolin and retinoic acid can stimulate the expression of junctin by activating specific signaling pathways that culminate in the transcription of genes encoding this calcium-regulating protein. These activators are diverse in structure and function, ranging from blockers of ion channels like nifedipine to local anesthetics such as tetracaine, each contributing to the upregulation of junctin expression by altering the internal cellular landscape, particularly the calcium dynamics. Collectively, these compounds can shape the expression profile of junctin, highlighting the complexity of cellular regulation and the exquisite sensitivity of muscle cells to changes in their biochemical milieu.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol may augment junctin expression by engaging β-adrenergic receptors, initiating a cascade that increases intracellular calcium concentration, which in turn stimulates signaling pathways specific to muscle contraction and cellular adaptation. | ||||||
L-phenylephrine | 59-42-7 | sc-295315 sc-295315A | 5 g 25 g | $181.00 $492.00 | 2 | |
L-phenylephrine could upregulate junctin by binding to α-adrenergic receptors, which may trigger a series of reactions leading to the enhanced release and storage of calcium within muscle cells, necessitating more junctin to handle the calcium influx. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin's inhibition of the Na+/K+ ATPase pump may indirectly heighten intracellular calcium, thus stimulating an upsurge in junctin expression to counterbalance the elevated calcium levels and maintain muscle cell function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can stimulate junctin expression by activating adenylate cyclase, increasing cAMP levels, which might stimulate protein kinases that phosphorylate transcription factors involved in the synthesis of junctin. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin's inhibition of the SERCA pumps leads to increased cytosolic calcium, which may stimulate the expression of junctin as the cell attempts to restore calcium sequestration capacity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, by blocking adenosine receptors, can lead to enhanced junctin expression due to its role in increasing intracellular calcium release from the sarcoplasmic reticulum during muscle excitation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can upregulate junctin expression by engaging nuclear receptors that trigger gene transcription processes, including those coding for proteins central to calcium signaling and muscle cell structure. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may enhance junctin levels by engaging glucocorticoid receptors, which can stimulate a gene expression profile conducive to maintaining muscle cell structure and function under stress conditions. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can induce junctin expression by inhibiting GSK-3 activity, leading to the activation of transcription factors that promote the synthesis of proteins necessary for calcium ion cycling within muscle cells. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine's blockade of L-type calcium channels may lead to a compensatory upregulation of junctin to rebalance the calcium ion concentrations within the sarcoplasmic reticulum. | ||||||